Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Revista Espanola De Cardiologia (English Ed.)|July 26, 2024
Efficacy and safety of bempedoic acid in acute coronary syndrome. Design of the clinical trial ES-BempeDACSSergio Raposeiras-Roubín, Emad Abu-Assi, José Ángel Pérez Rivera, et al.
The American Journal of Cardiology|September 21, 2023
Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF ScoreFabrizio D'Ascenzo, Enrico Fabris, Caterina DeGregorio, et al.
Journal of the American Heart Association|July 25, 2023
Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS RegistryFrancesco Bruno, Giorgio Marengo, Ovidio De Filippo, et al.
Cardiovascular Drugs and Therapy|July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational RegistriesMatteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Revista Espanola De Cardiologia (English Ed.)|June 30, 2018
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or PrasugrelSergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, et al.
European Journal of Preventive Cardiology|March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registryFabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
Revista Espanola De Cardiologia (English Ed.)|July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary SyndromeSergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
The Lancet. Digital Health|October 17, 2025
Extension of the GRACE score for non-ST-elevation acute coronary syndrome: a development and validation study in ten countriesFlorian A Wenzl, Klaus F Kofoed, Moa Simonsson, et al.
Pageof 16